ChemDiv chemistry of cures

Although a drug can show early promise, it is still a long way from being approved for marketing. After Proof Of Concept is established, large clinical trials are conducted in many different centers, frequently in several different countries to confirm that the drug is both safe and effective when used correctly for the suitable patient population. This phase can take up to 5 years and involves thousands of patients before the data can be submitted to the regulatory authorities for marketing approval (New Drug Approval - NDA). We are able to enroll more patients at a much faster rate and at a lower cost as compared to other European countries and the U.S. With faster enrollment, our clients can submit an NDA sooner, thereby increasing patent life of a drug. Only after the drug has been approved can it be marketed. ChemDiv leverages extensive clinical experience of its staff members to rapidly advance the drug candidate in multiple centers in Russia, Ukraine and Baltic States.

See Also:

---

Target to Lead
Lead to Candidate
Candidate to POC
Translational Research